Acquired immunodeficiency syndrome among adolescents. Case surveillance profiles in New York City and the rest of the United States. 1989

S H Vermund, and K Hein, and H D Gayle, and J M Cary, and P A Thomas, and E Drucker
Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.

Adolescents engaging in certain sexual or drug-related behavior are at risk of contracting the human immunodeficiency virus infection in endemic locales. Local and national surveillance data were analyzed to determine the characteristics of the acquired immunodeficiency syndrome (AIDS) epidemic on adolescents. Of the 605 cases of AIDS in people aged 13 to 21 years reported through 1987, 518 were males (83 from New York City [NYC], NY), and 87 were females (28 from NYC). Over half of all adolescent males with AIDS reported homosexual contact. Transfusion/blood product-related human immunodeficiency virus acquisitions (especially in males with hemophilia) represented 11% of adolescent cases from NYC (1% of NYC adults) and 22% of adolescent cases in the United States (US) outside of NYC (4% of adults in the US). Intravenous drug use was more frequently reported among adolescents with AIDS from NYC (23%) than among adolescents outside NYC (14%). In females, heterosexual transmission accounts for about half of all adolescent AIDS cases and 29% of all adult cases. Age-appropriate services and behavioral interventions are urgently needed for high-risk adolescents.

UI MeSH Term Description Entries
D008297 Male Males
D009519 New York City City located at the mouth of the Hudson River, in New York State.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012725 Sexual Behavior Sexual activities of humans. Anal Sex,Oral Sex,Sexual Activity,Sexual Orientation,Premarital Sex Behavior,Sex Behavior,Sex Orientation,Sexual Activities,Activities, Sexual,Activity, Sexual,Behavior, Premarital Sex,Behavior, Sex,Behavior, Sexual,Orientation, Sexual,Sex, Anal,Sex, Oral
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015528 HIV Seroprevalence Studies of the number of cases where human immunodeficiency virus (HIV) is present in a specific population at a designated time. The presence in a given individual is determined by the finding of HIV antibodies in the serum (HIV SEROPOSITIVITY). Seroprevalence, HIV

Related Publications

S H Vermund, and K Hein, and H D Gayle, and J M Cary, and P A Thomas, and E Drucker
August 1985, MMWR. Morbidity and mortality weekly report,
S H Vermund, and K Hein, and H D Gayle, and J M Cary, and P A Thomas, and E Drucker
July 1985, JAMA,
S H Vermund, and K Hein, and H D Gayle, and J M Cary, and P A Thomas, and E Drucker
December 1987, MMWR. Morbidity and mortality weekly report,
S H Vermund, and K Hein, and H D Gayle, and J M Cary, and P A Thomas, and E Drucker
August 1987, JAMA,
S H Vermund, and K Hein, and H D Gayle, and J M Cary, and P A Thomas, and E Drucker
January 1988, JAMA,
S H Vermund, and K Hein, and H D Gayle, and J M Cary, and P A Thomas, and E Drucker
October 1986, MMWR. Morbidity and mortality weekly report,
S H Vermund, and K Hein, and H D Gayle, and J M Cary, and P A Thomas, and E Drucker
July 1989, Pediatrics,
S H Vermund, and K Hein, and H D Gayle, and J M Cary, and P A Thomas, and E Drucker
December 1988, Archives of pathology & laboratory medicine,
S H Vermund, and K Hein, and H D Gayle, and J M Cary, and P A Thomas, and E Drucker
January 1986, MMWR. Morbidity and mortality weekly report,
S H Vermund, and K Hein, and H D Gayle, and J M Cary, and P A Thomas, and E Drucker
December 1986, MMWR. Morbidity and mortality weekly report,
Copied contents to your clipboard!